Skip to:

Catherine L. Carpenter

Adjunct Professor


DepartmentsType of Faculty
EpidemiologyJoint Appointment
Contact Information

UCLA Center for Human Nutrition
David Geffen School of Medicine at UCLA
14-193 Warren Hall
900 Veteran Ave, Box 951742
Los Angeles, CA 90095

Areas of Interest: 

My current research areas include: diet and exercise intervention studies for breast cancer prevention; the effect of protein on recovery from malnutrition and HIV; the influence of candidate genes associated with appetite and food craving in development of obesity; and lung cancer prevention through dietary consumption of cruciferous vegetables.  Future research directions include studies of macronutrient and micronutrient intake, malnutrition, and infectious disease, and development of epidemiologic methods to account for dietary compensation in nutritional trials.

Dr. Carpenter received her doctoral training in Epidemiology at UCLA.  She completed a postdoctoral fellowship in Preventive Medicine at USC where she studied lifetime exercise, obesity, and breast cancer risk and prognosis.   After completing her postdoc, she started at UC Irvine as an Assistant Professor in Cancer Epidemiology where she continued her studies in breast and lung cancer and further developed a focus on obesity and nutrition.   She started at the UCLA Center for Human Nutrition in 2003, and has since broadened her research to include studies of food addiction, genetics, and the role of nutrition in the prevention and recovery from infectious diseases.  Dr. Carpenter has conducted the design and analysis of several randomized nutritional intervention trials using clinic and population sampling.  Dr. Carpenter also has appointments in Medicine and Nursing as well as in Epidemiology.  Dr. Carpenter will be teaching Nutritional Epidemiology.

PhD Epidemiology, minor in Biostatistics, UCLA
MPH Epidemiology and Biostatistics, UC Berkeley
BA Zoology, UC Berkeley
This faculty member is available to serve as: 
Masters Advisor
MS Report Committee Member
Field Studies Advisor

Please check with the faculty member or their office about availability to serve during current academic period.

Selected Publications: 


Nyamathi A, Sinha S, Ganguly KK, Suresh P, Carpenter CL.  Impact of protein supplementation and care and support on body composition and CD4 count among HIV-infected women living in rural India:  results from a randomized pilot clinical trial using trained village women.  AIDS and Behav, 2013, epub, DOI 10.1007/s10461-013-0420-5. 


Carpenter CL, Yan E, Chen S, Hong K, Arechiga A, Kim WS, Deng ML, Arteaga J, Li Z, Heber D.  Body fat and body-mass index among a multi-ethnic sample of college-age men and women. J Obesity, 2013, vol. 2013, Article ID 790654, 7 pages. doi:10.1155/2013/790654.


Carpenter CL, Wong AM, Li, Z, Noble EP, Heber D.  Association of D2 dopamine receptor and leptin receptor genes with clinically severe obesity.  Obesity, 2012, epub, DOI 10.1002/oby.20202.


Carpenter CL, Duvall K, Jardack P, Li L, Henning SM, Li Z, Heber D.  Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women:  a single arm intervention pilot study.  Nutrition Journal, 2012,11:102.


Robbins W, Xun L, Fitzgerald LZ, Esguerra S, Henning SM, Carpenter CL. Walnuts improve semen quality in men consuming a western-style diet: randomized control dietary intervention trial.  Biol Reprod. 2012, 87:101.  


Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L.  The roles of herbal remedies and quality of life among long-term breast cancer survivors – results of a prospective study.  BMC Cancer, 2011;11:222.


Carpenter CL, Ganz PA, Bernstein L.  Complementary and alternative therapies among very long-term breast cancer survivors.  Br Cancer Res Treat, 2009;116:387-396.


Carpenter CL, Yu MC, London SJ.  Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California.  Nutr Cancer, 2009;61:492-499.


Tsou JA, Kazarian M, Patel A, Galler JS, Laird-Offringa IA, Carpenter CL, London SJ.  Low level anti-Hu reactivity:  A risk marker for small cell lung cancer?  Cancer Detect Prev, 2009:32:292-299.